Serum homocysteine is weakly associated with von Willebrand factor and soluble vascular cell adhesion molecule I, but not with C-reactive protein in type 2 diabetic and non-diabetic subjects - The Hoorn Study

European Journal of Clinical Investigation

Volumn 30, Issue 9, 2000, Pages 763-770

  Becker, ^a,b,c,d   Van Hinsbergh, ^a,b,c,d   Kostense, ^a,b,c,d   Jager, ^a,b,c,d   Dekker, ^a,b,c,d   Nijpels, ^a,b,c,d   Heine, ^a,b,c,d   Bouter, ^a,b,c,d   Stehouwer, ^a,b,c,d  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b TNO   (Netherlands)

^c SLOTERVAART HOSPITAL   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

C reactive protein; Homocysteine; Soluble vascular cell adhesion molecule 1; Type 2 diabetes

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; HOMOCYSTEINE; TRIACYLGLYCEROL; UREA; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; INFLAMMATION; LEUKOCYTE ADHERENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; REGRESSION ANALYSIS; THROMBOSIS; VASCULAR ENDOTHELIUM;

AGED; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CELL ADHESION MOLECULES; DIABETES MELLITUS, TYPE 2; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; VON WILLEBRAND FACTOR;

EID: 0033821578     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00706.x     Document Type: Article

References (47)

1. Homocysteine and vascular disease
2. Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly man
3. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus
4. Plasma homocysteine concentration predicts mortality in non-insulin dependent diabetic patients with and without albuminuria
5. Fasting and post-methionine homocysteine levels in NIDDM
6. Plasma homocysteine and all-cause mortality in diabetes
7. Hyperhomocysteinemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease
8. Endothelial marker proteins in hyperhomocysteinemia
9. Hyperhomocysteinaemia and endothelial dysfunction in peripheral arterial disease
10. Acute hyperhomocysteinaemia and endothelial dysfunction
11. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans
12. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilatation in humans
13. Atherosclerosis - An inflammatory disease
14. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1
15. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells
16. Carotid artery stenosis is related to blood glucose level in an elderly Caucasian population
17. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus
18. Von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia
19. Hemostatic factors and the risk of myocardial infarction or sudden death in patients wih angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
20. Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction
21. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis
22. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease
23. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes
24. Production of C-reactive protein and risk of coronary events in stable and instable angina
25. Relation of C-reactive protein and coronary heart disease in the MRFIT-nested case-control study
26. Von Willebrand factor, C-reactive protein and five year mortality in diabetic and non-diabetic subjects
27. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum
28. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
29. Plasma homocysteine as a risk factor for vascular disease
30. Homocysteine and atherothrombosis
31. Von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death
32. Von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction
33. Study: Hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients
34. Von Willebrand factor and factor VIII. C in acute cerebrovascular disease. Relationship to stroke, subtype and mortality
35. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-Year follow-up of the Hoorn Study
36. Plasma homocysteine concentration related to diet, endothelial function and mononunclear cell gene expression among male hyperlipidaemic smokers
37. Plasma homocysteine is weakly correlated with plasma endothelin and von Willebrand factor, but not with endothelium-dependent vasodilatation in healthy postmenopausal women
38. Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease
39. High prevalence of hyperhomocysteinemia and asymptomatic vascular disease in siblings of young patients with vascular disease and hyperhomocysteinemia
40. Normohomocysteinemia and vitamin-treated hyperhomocysteinemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study
41. An alternative view of homocysteine
42. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
43. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: Results from the Cardiovascular Health Study and the Rural Health Promotion Project
44. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
45. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
46. Homocysteine, vitamins, and cardiovascular disease